Hayley Jones: Advancing Global Equity in Cancer Registration at IARC60

by Chief Editor

Closing the Global Data Gap: The Future of Cancer Registration

For decades, the fight against cancer has been hampered by a silent crisis: a lack of reliable data. Currently, only 21% of the world’s population is covered by population-based cancer registries. Without accurate, systematic data, health systems are essentially fighting in the dark, unable to identify inequities or track the efficacy of treatments.

However, a major shift is underway. The launch of the new Legal Framework for Cancer Registries Toolkit, presented at the IARC60 conference, signals a move toward standardized, legally mandated reporting. This isn’t just about paperwork; We see a foundational step toward global health equity.

Why Legal Frameworks Are the Missing Link

Data collection is often seen as a technical challenge, but it is fundamentally a legal one. To build a robust registry, countries must navigate complex issues of privacy, mandatory reporting and data governance. Without a clear legal mandate, registries often struggle with inconsistent reporting and fragmented information.

Why Legal Frameworks Are the Missing Link
Advancing Global Equity Without
Pro Tip: When drafting a legal framework for health data, focus on “privacy by design.” Regulations that mandate reporting while explicitly protecting patient identity are more likely to gain public trust and achieve high compliance rates.

The Shift Toward Global Standardization

The future of cancer registration lies in the move away from “one-size-fits-all” solutions. As highlighted by the collaboration between the McCabe Centre for Law and Cancer and the International Agency for Research on Cancer (IARC), the trend is toward adaptable, modular legal tools. This allows nations—from South Africa to the Republic of Korea—to draft laws that align with international best practices while respecting local legal contexts.

What In other words for Global Health Equity

Better data leads to better policy. When governments can accurately track cancer incidence and mortality, they can:

What In other words for Global Health Equity
Advancing Global Equity Identify Inequities
  • Identify Inequities: Spot specific demographics or regions that are disproportionately affected.
  • Allocate Resources: Direct funding and screening programs where they are needed most.
  • Measure Impact: Evaluate whether national cancer control plans are actually saving lives.
Did you know? Population-based cancer registries are the “gold standard” for cancer surveillance. They track all new cases in a defined population, providing a much clearer picture of disease trends than hospital-based registries alone.

Looking Ahead: The Role of Technology and Policy

As we move further into the decade, expect to see an integration of digital health records with national registry systems. The challenge will be ensuring that as we digitize, we maintain the strong legal safeguards outlined in the new IARC toolkit. The goal is a seamless, automated flow of data that minimizes the burden on clinicians while maximizing the quality of public health intelligence.

Frequently Asked Questions (FAQ)

Q: Why is a legal framework necessary for cancer registries?
A: A legal framework ensures that reporting is mandatory, consistent, and secure. It provides the legal authority for health agencies to collect data, which is essential for ensuring high-quality, systematic information across an entire population.

Q: Can any country use the IARC/McCabe Centre toolkit?
A: Yes. The toolkit is designed to be adaptable. It provides a structured approach—including templates and “quick start” guides—that can be customized to fit the specific legal and cultural requirements of any nation.

Q: How do cancer registries help reduce health inequities?
A: By providing a precise map of where cancer occurs and who it affects, registries allow policymakers to see gaps in access to screening, diagnosis, and treatment, enabling them to direct resources to underserved communities.


Are you involved in public health policy or cancer surveillance? We want to hear from you. Share your experiences with registry development in the comments below or subscribe to our newsletter for the latest updates on global oncology initiatives.

You may also like

Leave a Comment